Imuldosa
Product Images NDC 51407-931

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Imuldosa (NDC 51407-931). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Imuldosa 01)

Figure A (Imuldosa 01)
An illustrated diagram showing five medical supplies arranged horizontally: an adhesive bandage, antiseptic wipes, a cotton ball or gauze pads, an IMULDOSA prefilled syringe, and an FDA-cleared sharps disposal container. Each item is labeled below the illustration, representing components related to the IMULDOSA product line by Golden State Medical Supply, Inc.*
FDA Label Image

Figure B (Imuldosa 02)

Figure B (Imuldosa 02)
A detailed black and white diagram illustrating the labeled parts of a syringe-like device. Components labeled include plunger head, plunger, needle guard wings, needle guard activation clips, safety guard spring, body, label, extended finger flanges, needle, and needle cover. The diagram shows these parts in a linear layout from the plunger head on the left to the needle cover on the right.*
FDA Label Image

Figure C (Imuldosa 03)

Figure C (Imuldosa 03)
An instructional illustration showing recommended injection sites for IMULDOSA on the human body. The diagram highlights areas on the upper thigh, upper arm, lower abdomen, and buttocks for administration, presented on front and rear views of a simplified human figure.*
FDA Label Image

Figure D (Imuldosa 04)

Figure D (Imuldosa 04)
An instructional diagram showing hands preparing a syringe and a small cap or cover. One hand is holding a syringe with the plunger partially pulled, and the other hand is holding a small object, demonstrating a pulling or separating action indicated by arrows pointing outward.*
FDA Label Image

Figure E (Imuldosa 05)

Figure E (Imuldosa 05)
An instructional line drawing showing a hand holding a syringe, positioned for injection with an arrow indicating the direction of administration into a patient's arm.*
FDA Label Image

Figure F (Imuldosa 06)

Figure F (Imuldosa 06)
An instructional illustration showing a hand administering an injection at a 45-degree angle into the skin of a knee area. The syringe is held in one hand with the needle positioned above the skin, and the other hand rests nearby on the knee.*
FDA Label Image

Figure G (Imuldosa 07)

Figure G (Imuldosa 07)
An instructional line drawing showing a hand holding a needle with a labeled feature called "Needle Guard Wings." The illustration focuses on demonstrating the location and use of these needle guard wings on the device.*
FDA Label Image

Figure H (Imuldosa 08)

Figure H (Imuldosa 08)
An instructional line drawing showing a hand holding a syringe with a spring mechanism. The hand is pulling back on the syringe plunger, indicated by an arrow pointing away from the syringe, suggesting preparation or priming of the injection device. The image is likely part of usage instructions for IMULDOSA by Golden State Medical Supply, Inc.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A line graph titled 'PsA STUDY 1' showing the percentage of patients over 24 weeks for three groups: placebo, ustekinumab 45 mg, and ustekinumab 90 mg. The x-axis represents time in weeks, and the y-axis represents the percentage of patients. Data points demonstrate that both ustekinumab groups have higher patient percentages compared to placebo over time.*
FDA Label Image

Needle Wings (Needle Guard Wings)

Needle Wings (Needle Guard Wings)
An instructional line drawing showing a hand holding a syringe with the focus on the needle guard wings, which are labeled and pointed out by an arrow. The illustration highlights the needle safety feature on the syringe.*
FDA Label Image

Plunger Head (Plunger Head)

Plunger Head (Plunger Head)
An instructional line drawing showing a hand holding a prefilled syringe, demonstrating the action of pulling back the plunger with an arrow indicating the motion. This diagram appears to illustrate the proper technique for preparing or using the syringe, likely related to the administration of IMULDOSA.*
FDA Label Image

Syringe (Syringe Label)

Syringe (Syringe Label)
An anatomical line drawing diagram of an IMULDOSA syringe showing labelled parts, including the plunger head, plunger, needle guard wings, needle guard activation clips, safety guard spring, body, extended finger flanges, needle, label, and needle cover. The diagram displays the syringe components in a partially exploded view.*
FDA Label Image

Ustekinumab_130 mg Carton-gsms.jpg (Ustekinumab 130 mg Carton Gsms)

Ustekinumab_130 mg Carton-gsms.jpg (Ustekinumab 130 mg Carton Gsms)
IMULDOSA (ustekinumab-srIf) Injection 130 mg/26 mL (5 mg/mL) single-dose vial label and carton. The packaging includes storage instructions referencing refrigeration at 2°C to 8°C, and notes that the product is for intravenous infusion only and must be diluted. The labeler Golden State Medical Supply, Inc. is indicated, with manufacturer information for Accord BioPharma Inc. and Catalent Indiana, LLC. The carton contains dosing and dispensing information and the GSMS logo.*
FDA Label Image

Ustekinumab_45 mg Pfs Carton-gsms.jpg (Ustekinumab 45 mg Pfs Carton Gsms)

Ustekinumab_45 mg Pfs Carton-gsms.jpg (Ustekinumab 45 mg Pfs Carton Gsms)
IMULDOSA (ustekinumab-srlf) Injection 45 mg/0.5 mL single-dose prefilled syringe packaging label. The label shows dosage strength, administration route for subcutaneous use, and storage instructions. The labeler is Golden State Medical Supply, Inc., with a GTIN barcode and NDC 51407-929-11 visible. The packaging includes manufacturer information and a note to dispense the enclosed Medication Guide to each patient.*
FDA Label Image

Ustekinumab_90 mg Pfs Carton (GSMS.jpg)

Ustekinumab_90 mg Pfs Carton (GSMS.jpg)
IMULDOSA (ustekinumab-srIf) Injection 90 mg/mL pharmaceutical carton label. The label indicates the product is for subcutaneous use and prescription only. It includes storage instructions to keep refrigerated between 36°F to 46°F, warnings to protect from light, and dosage instruction referencing the prescribing information. The label also includes manufacturing and marketing details as well as a 2D barcode representation area. Labeler is Golden State Medical Supply, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.